Fresenius Medical Care AG
FMSHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeFresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. At a $11.62B market cap, Fresenius Medical Care AG ranks as a large-cap company within healthcare. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Market Cap
$11.62B
Beta
0.82
P/E (TTM)
11.38
P/E (Fwd)
5.51
EPS (TTM)
$1.90
EPS (Fwd)
$3.93
ROE
7.8%
ROA
3.6%
Cash
$1.24B
Total Debt
$11.04B
Free CF
$1.67B
52W Change
-23.8%
Annual Financials
Cash vs Debt
The company holds $1.24B in cash, though total debt stands at $11.04B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $1.67B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 7.8%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.6% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $17.62B to $19.63B.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Fresenius Medical Care AG and its sector.